The Patent Finder

Salutria Pharmaceuticals LLC

Also on record
Records under this name other than patents Salutria Pharmaceuticals LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Salutria Pharmaceuticals LLC

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,121,319Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
Term ended
Term ended May 14, 2018 · USPTO record
Term endedTerm ended May 14, 2018USPTO record
US 6,147,250Compounds and methods for the inhibition of the expression of VCAM-1
Term ended
Term ended May 14, 2018 · USPTO record
Term endedTerm ended May 14, 2018USPTO record
US 8,252,840Methods of derivatives of probucol for the treatment of type II diabetes
Lapsed on the fee record
Ended Aug 28, 2016 · USPTO record
Lapsed on the fee recordEnded Aug 28, 2016USPTO record
US 7,294,737Process of preparing esters and ethers of probucol and derivatives thereof
Lapsed on the fee record
Ended Nov 13, 2015 · USPTO record
Lapsed on the fee recordEnded Nov 13, 2015USPTO record
US 7,273,948Process of preparing esters and ethers of probucol and derivatives thereof
Lapsed on the fee record
Ended Sep 25, 2015 · USPTO record
Lapsed on the fee recordEnded Sep 25, 2015USPTO record
US 7,271,274Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
Lapsed on the fee record
Ended Sep 18, 2015 · USPTO record
Lapsed on the fee recordEnded Sep 18, 2015USPTO record
US 6,617,352Compounds and methods for the inhibition of the expression of VCAM-1
Lapsed on the fee record
Ended Sep 9, 2015 · USPTO record
Lapsed on the fee recordEnded Sep 9, 2015USPTO record
US 6,602,914Compounds and methods for the inhibition of the expression of VCAM-1
Lapsed on the fee record
Ended Aug 5, 2015 · USPTO record
Lapsed on the fee recordEnded Aug 5, 2015USPTO record
US 7,247,714Protection against oxidative stress and inflammation by a cytoprotective response element
Lapsed on the fee record
Ended Jul 24, 2015 · USPTO record
Lapsed on the fee recordEnded Jul 24, 2015USPTO record
US 6,548,699Compounds and methods for the inhibition of the expression of VCAM-1
Lapsed on the fee record
Ended Apr 15, 2015 · USPTO record
Lapsed on the fee recordEnded Apr 15, 2015USPTO record
10 of 31 patents shown.
Pro members see all 31.
Pro members: see all 31 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited